Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 256

Results For "IMA"

2853 News Found

WHO gives its go-ahead for first-ever malaria vaccine
Drug Approval | October 07, 2021

WHO gives its go-ahead for first-ever malaria vaccine

It recommends using the vaccine to prevent the spread of the disease


Janssen announces novel mechanism that shows promise against dengue
Biotech | October 07, 2021

Janssen announces novel mechanism that shows promise against dengue

Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats


U.S. FDA clears Venclose Maven to treat incompetent perforator veins
Medical Device | October 07, 2021

U.S. FDA clears Venclose Maven to treat incompetent perforator veins

Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years


Lupin receives tentative approval for Brexpiprazole tablets
Drug Approval | October 06, 2021

Lupin receives tentative approval for Brexpiprazole tablets

This product will be manufactured at Lupin’s Pithampur facility In India


Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all  districts
Public Health | October 06, 2021

Pradhan Mantri Bhartiya Janaushadhi Pariyojana stores open in all districts

A total of 8308 stores are open across India and medicines are priced at affordable rates


Temasek to buy a stake in Integrace
Startup | October 05, 2021

Temasek to buy a stake in Integrace

The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition


AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
Biotech | October 05, 2021

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid

The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)


Biocon launches Everolimus tablets in the US
Drug Approval | October 04, 2021

Biocon launches Everolimus tablets in the US

According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021


Pfizer transfers certain medicines to Mylan as part of an agreement
News | October 04, 2021

Pfizer transfers certain medicines to Mylan as part of an agreement

The consideration for the medicines in India is valued at Rs 180.48 crore


Thermo Fisher opens biologics site in Lengnau, Switzerland
News | October 04, 2021

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production